Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/24/19 → 6/23/21 |
Funding
- Pfizer, Inc.: $74,780.57
(RSV Pfizer) A PHASE 2b, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN 18 THROUGH 49 YEARS OF AGE AND THEIR INFANTS
- Saad, Antonio (PI)
Project: Other project